The InsilicAll Platform: Drug Discovery through Artificial Intelligence and Big Data

Vol. 1, 2019 - 111757
Poster only
Favorite this paper
How to cite this paper?
Abstract

InsillicAll is an integrated end-to-end platform based on cloud computing for the personalized acceleration of drug discovery, chemical development, and chemical safety assessment campaigns. Our platform has been designed to be used by scientists in pharmaceutical, cosmetics, veterinary, and crop industries. Our vision is to be an integral utility platform in the R&D value chain and to support the work of scientists in a collaborative manner. Our packages rDrug®, PHAARM MatchMaker®, and Detoxie® provide an integrated workflow for hit-to-lead discovery and development of drugs, pharmacokinetics evaluation, prediction of many off targets, and drug repositioning for patent protection strategies. We believe this integrated workflow will enable scientists, biochemists, medical chemists, to make faster, cheaper, and more efficient decisions.

Institutions
  • 1 Insilicall
Track
  • 1. Strategies in Drug Design
Keywords
drug design
Artificial Intelligence
Big Data
Drug Discovery